{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T21:42:53Z","timestamp":1787694173620,"version":"build-2784847793"},"reference-count":35,"publisher":"Scientific Scholar","content-domain":{"domain":["ijmr.org.in"],"crossmark-restriction":true},"short-container-title":["Indian J Med Res"],"abstract":"\nBackground & objectives<\/jats:title>\nAlthough multi-drug therapy has decreased the burden of disease, leprosy is yet to be eliminated. Accelerating progress requires optimal use of existing tools, advanced diagnostic tests, newer drugs, and vaccines. The search for a vaccine with therapeutic and preventive potential is ongoing, but evidence on effectiveness and safety is lacking. This systematic review and meta-analysis will evaluate and compare the clinical efficacy, immunogenicity, and safety of leprosy vaccines in humans.<\/jats:p>\n<\/jats:sec>\n\nMethods<\/jats:title>\nIn June 2024, three databases were systematically searched with updated search keywords. Randomized controlled trials (RCTs) pertaining to leprosy vaccines for humans which evaluated either therapeutic or prophylactic vaccines in leprosy with a placebo or active comparator arm, with full-text access, were included in the study. There were no restrictions on language, country or date. For the risk of bias assessment in the studies included, the revised Cochrane risk-of-bias 2 tool for RCTs was used. A P<\/jats:italic> value (two-sided) of <0.05 was considered as significant for all tests; however for heterogeneity, a one-sided P<\/jats:italic> value of <0.1 was considered as statistically significant. The quality of generated evidence specific to the desired outcomes were assessed using the GRADE approach (Grading of Recommendations Assessment, Development and Evaluation). The study protocol was registered in PROSPERO (ID: CRD42024561651).<\/jats:p>\n<\/jats:sec>\n\nResults<\/jats:title>\nA total of 2163 studies were retrieved from different databases. After removing duplicates and full text screening, 12 articles were finally selected. Out of these studies, eight used leprosy vaccines on prophylactic basis, while four used leprosy vaccines on therapeutic basis. In therapeutic use of leprosy vaccine, Ramu\u2019s score was found to be significantly protective [-3.06 (95% confidence interval (CI): -3.96 to -2.16)] among the recipients of the therapeutic leprosy vaccine. Bacterial index was found to be insignificant [-0.26 (95% CI: -1.54 to 1.03)] among the recipients of therapeutic leprosy vaccine. In subgroup analysis among the eight prophylactic vaccine studies, pooled relative risk was found to be 0.61 (95% CI: 0.41 \u2013 0.91).<\/jats:p>\n<\/jats:sec>\n\nInterpretation & conclusions<\/jats:title>\nThe findings of this meta-analysis suggest that both prophylactic and therapeutic leprosy vaccines were significantly better compared to the placebo. Leprosy vaccine in the form of Mw\/Mycobacterium welchii<\/jats:italic>\/MIP along with combination of World Health Organization (WHO) multi-drug therapy (MDT) or Bacillus Calmette-Guerin (BCG) vaccine along with second line treatment with rifampicin were found to be protective among the recipients.<\/jats:p>\n<\/jats:sec>","DOI":"10.25259\/ijmr_1289_2024","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T07:33:55Z","timestamp":1732779235000},"page":"293-302","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of leprosy vaccines across the globe: A systematic review & meta-analysis of randomized controlled trials"],"prefix":"10.25259","volume":"160","author":[{"given":"Shreyashi","family":"Dasgupta","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Pharmacology, School of Tropical Medicine, Kolkata, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shatavisa","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Pharmacology, School of Tropical Medicine, Kolkata, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiranjib","family":"Bagchi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Tamralipto Government Medical College & Hospital, Kolkata, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saibal","family":"Das","sequence":"additional","affiliation":[{"name":"ICMR-Centre for Ageing and Mental Health, Kolkata, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indranil","family":"Saha","sequence":"additional","affiliation":[{"name":"ICMR-Centre for Ageing and Mental Health, Kolkata, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Kalita","sequence":"additional","affiliation":[{"name":"ICMR-Centre for Ageing and Mental Health, Kolkata, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavani Shankara","family":"Bagepally","sequence":"additional","affiliation":[{"name":"Division of Health Systems Research, ICMR-National Institute of Epidemiology, Chennai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhasish Kamal","family":"Guha","sequence":"additional","affiliation":[{"name":"School of Tropical Medicine, Kolkata, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"key":"10.25259\/IJMR_1289_2024\/ref-1","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1309\/AJCPP72FJZZRRVMM","article-title":"A new Mycobacterium species causing diffuse lepromatous leprosy","volume":"130","author":"Han","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.25259\/IJMR_1289_2024\/ref-3","volume-title":"Davidson\u2019s Principles and Practice of Medicine","author":"Penman","year":"2023","edition":"24th ed"},{"key":"10.25259\/IJMR_1289_2024\/ref-5","volume-title":"IAL textbook of leprosy","year":"2023","edition":"3rd ed"},{"key":"10.25259\/IJMR_1289_2024\/ref-6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/ijmr.ijmr_64_24","article-title":"Eradication of leprosy from India: Reflections on past, present & future","volume":"159","author":"Katoch","year":"2024","journal-title":"Indian J Med Res"},{"key":"10.25259\/IJMR_1289_2024\/ref-8","first-page":"585","article-title":"National sample survey to assess the new case disease burden of leprosy in India","volume":"146","author":"Katoch","year":"2017","journal-title":"Indian J Med Res"},{"key":"10.25259\/IJMR_1289_2024\/ref-11","doi-asserted-by":"crossref","first-page":"7125","DOI":"10.1016\/j.vaccine.2009.09.054","article-title":"Protective effect of the combination BCG vaccination and rifampicin prophylaxis in leprosy prevention","volume":"27","author":"Schuring","year":"2009","journal-title":"Vaccine"},{"key":"10.25259\/IJMR_1289_2024\/ref-12","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1371\/journal.pntd.0000167","article-title":"BCG revaccination does not protect against leprosy in the Brazilian Amazon: A cluster randomised trial","volume":"2","author":"Cunha","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"10.25259\/IJMR_1289_2024\/ref-13","first-page":"17e24","article-title":"Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi","volume":"348","author":"Karonga Prevention Trial Group","year":"1996","journal-title":"Lancet"},{"key":"10.25259\/IJMR_1289_2024\/ref-14","first-page":"175","article-title":"Immunological properties of M. leprae culture isolates ICRC bacilli: Hypothesis on relationship between M. leprae and ML-culture isolates","volume":"2","author":"Bapat","year":"1984","journal-title":"Acta Leprol"},{"key":"10.25259\/IJMR_1289_2024\/ref-15","first-page":"369","article-title":"Comparative leprosy vaccine trial in south India","volume":"70","author":"Gupte","year":"1998","journal-title":"Indian J Lepr"},{"key":"10.25259\/IJMR_1289_2024\/ref-16","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.meegid.2007.07.009","article-title":"The use of the name Mycobacterium w for the leprosy immunotherapeutic bacillus creates confusion with M. tuberculosis-W (Beijing strain): A suggestion","volume":"8","author":"Talwar","year":"2008","journal-title":"Infect Genet Evol"},{"key":"10.25259\/IJMR_1289_2024\/ref-17","first-page":"179","article-title":"Response of Mycobacterium habana vaccine in patients with lepromatous leprosy and their household contacts. A pilot clinical study","volume":"72","author":"Wakhlu","year":"2001","journal-title":"Lepr Rev"},{"key":"10.25259\/IJMR_1289_2024\/ref-18","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.vaccine.2019.12.050","article-title":"A phase 1 antigen dose escalation trial to evaluate safety, tolerability and immunogenicity of the leprosy vaccine candidate LepVax (LEP-F1 + GLA-SE) in healthy adults","volume":"38","author":"Duthie","year":"2020","journal-title":"Vaccine"},{"key":"10.25259\/IJMR_1289_2024\/ref-19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41541-018-0050-z","article-title":"LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection","volume":"3","author":"Duthie","year":"2018","journal-title":"NPJ Vaccines"},{"key":"10.25259\/IJMR_1289_2024\/ref-20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/ijmr.IJMR_661_20","article-title":"Cost-effectiveness of incorporating Mycobacterium indicus pranii vaccine to multidrug therapy in newly diagnosed leprosy cases for better treatment outcomes & immunoprophylaxis in contacts as leprosy control measures for National Leprosy Eradication Programme in India","volume":"154","author":"Muniyandi","year":"2021","journal-title":"Indian J Med Res"},{"key":"10.25259\/IJMR_1289_2024\/ref-21","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","year":"2019","edition":"2nd ed"},{"key":"10.25259\/IJMR_1289_2024\/ref-22","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.25259\/IJMR_1289_2024\/ref-23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.25259\/IJMR_1289_2024\/ref-24","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","article-title":"GRADE guidelines: 14. Going from evidence to recommendations: The significance and presentation of recommendations","volume":"66","author":"Andrews","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.25259\/IJMR_1289_2024\/ref-25","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jclinepi.2013.02.003","article-title":"GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation\u2019s direction and strength","volume":"66","author":"Andrews","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.25259\/IJMR_1289_2024\/ref-26","first-page":"389","article-title":"BCG vaccination in leprosy: Final results of the trial in Karimui, Papua New Guinea, 1963-79","volume":"67","author":"Bagshawe","year":"1989","journal-title":"Bull World Health Organ"},{"key":"10.25259\/IJMR_1289_2024\/ref-27","first-page":"323","article-title":"BCG vaccination of children against leprosy: Seven-year findings of the controlled WHO trial in Burma","volume":"48","author":"Bechelli","year":"1973","journal-title":"Bull World Health Organ"},{"key":"10.25259\/IJMR_1289_2024\/ref-28","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/0140-6736(92)91056-E","article-title":"Immunoprophylactic trial with combined Mycobacterium leprae\/BCG vaccine against leprosy: Preliminary results","volume":"339","author":"Convit","year":"1992","journal-title":"Lancet"},{"key":"10.25259\/IJMR_1289_2024\/ref-29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.47276\/lr.76.2.127","article-title":"Immunoprophylactic effects of the anti-leprosy Mw vaccine in household contacts of leprosy patients: Clinical field trials with a follow up of 8-10 years","volume":"76","author":"Sharma","year":"2005","journal-title":"Lepr Rev"},{"key":"10.25259\/IJMR_1289_2024\/ref-30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1017\/S002217240006945X","article-title":"BCG vaccination of children against leprosy in Uganda: Final results","volume":"87","author":"Stanley","year":"1981","journal-title":"J Hyg (Lond)"},{"key":"10.25259\/IJMR_1289_2024\/ref-31","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1016\/S0264-410X(01)00052-4","article-title":"Vaccination against leprosy at Ben San Leprosy Centre, Ho Chi Minh City, Vietnam","volume":"19","author":"Truoc","year":"2001","journal-title":"Vaccine"},{"key":"10.25259\/IJMR_1289_2024\/ref-32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/infdis\/167.2.401","article-title":"Combined multidrug and Mycobacterium w vaccine therapy in patients with multibacillary leprosy","volume":"167","author":"Zaheer","year":"1993","journal-title":"J Infect Dis"},{"key":"10.25259\/IJMR_1289_2024\/ref-33","first-page":"105","article-title":"Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy","volume":"73","author":"Narang","year":"2005","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.25259\/IJMR_1289_2024\/ref-34","first-page":"283","article-title":"Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion","volume":"68","author":"Majumder","year":"2000","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.25259\/IJMR_1289_2024\/ref-35","first-page":"187","article-title":"Impact of combined Mycobacterium w vaccine and 1 year of MDT on multibacillary leprosy patients","volume":"69","author":"De Sarkar","year":"2001","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.25259\/IJMR_1289_2024\/ref-37","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.4161\/hv.7.11.16848","article-title":"Advances and hurdles on the way toward a leprosy vaccine","volume":"7","author":"Duthie","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.25259\/IJMR_1289_2024\/ref-38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/0378-6323.31888","article-title":"Immunoprophylaxis of leprosy: Current status and future prospects","volume":"73","author":"Sehgal","year":"2007","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.25259\/IJMR_1289_2024\/ref-39","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/erv.09.161","article-title":"BCG vaccination and leprosy protection: Review of current evidence and status of BCG in leprosy control","volume":"9","author":"Merle","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.25259\/IJMR_1289_2024\/ref-40","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.cmi.2021.07.032","article-title":"Efficacy of chemoprophylaxis and immunoprophylaxis in leprosy prevention: A systematic review and network meta-analysis of randomized controlled trials","volume":"27","author":"Tawfik","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.25259\/IJMR_1289_2024\/ref-41","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1473-3099(06)70412-1","article-title":"The role of BCG in prevention of leprosy: A meta-analysis","volume":"6","author":"Setia","year":"2006","journal-title":"Lancet Infect Dis"}],"container-title":["The Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ijmr.org.in\/efficacy-of-leprosy-vaccines-across-the-globe-a-systematic-review-meta-analysis-of-randomized-controlled-trials\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/ijmr.org.in\/efficacy-of-leprosy-vaccines-across-the-globe-a-systematic-review-meta-analysis-of-randomized-controlled-trials\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T03:29:53Z","timestamp":1734665393000},"score":1,"resource":{"primary":{"URL":"http:\/\/ijmr.org.in\/efficacy-of-leprosy-vaccines-across-the-globe-a-systematic-review-meta-analysis-of-randomized-controlled-trials\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":35,"alternative-id":["10.25259\/IJMR_1289_2024"],"URL":"https:\/\/doi.org\/10.25259\/ijmr_1289_2024","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,27]]},"article-number":"293"}}